These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16508142)

  • 1. Synergistic effect of [10]-gingerol and aminoglycosides against vancomycin-resistant enterococci (VRE).
    Nagoshi C; Shiota S; Kuroda T; Hatano T; Yoshida T; Kariyama R; Tsuchiya T
    Biol Pharm Bull; 2006 Mar; 29(3):443-7. PubMed ID: 16508142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of antimicrobial activity of aminoglycosides by carnosol from Salvia officinalis.
    Horiuchi K; Shiota S; Kuroda T; Hatano T; Yoshida T; Tsuchiya T
    Biol Pharm Bull; 2007 Feb; 30(2):287-90. PubMed ID: 17268067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin resistance reversal in enterococci by flavonoids.
    Liu LX; Durham DG; Richards RM
    J Pharm Pharmacol; 2001 Jan; 53(1):129-32. PubMed ID: 11206187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
    Kak V; You I; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):297-9. PubMed ID: 10974585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of glycopeptides, aminoglycosides and macrolide resistance among Enterococcus faecalis and Enterococcus faecium isolates from hospitals in Tehran.
    Emaneini M; Aligholi M; Aminshahi M
    Pol J Microbiol; 2008; 57(2):173-8. PubMed ID: 18646406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterococci and aminoglycosides: evaluation of susceptibility and synergism of their combination with piperacillin.
    Stefani S; Russo G; Nicolosi VM; Nicoletti G
    Chemioterapia; 1987 Feb; 6(1):12-6. PubMed ID: 3103929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.
    Kariyama R; Kumon H; Chow L; Zervos MJ; Takata T; Tabata M; Chow JW
    J Antimicrob Chemother; 1998 Dec; 42(6):836-8. PubMed ID: 10052913
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial activity of oleanolic acid from Salvia officinalis and related compounds on vancomycin-resistant enterococci (VRE).
    Horiuchi K; Shiota S; Hatano T; Yoshida T; Kuroda T; Tsuchiya T
    Biol Pharm Bull; 2007 Jun; 30(6):1147-9. PubMed ID: 17541170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity of enterococci harboring the high-level gentamicin resistance gene aac(6')-Ie-aph(2'')-Ia or aph(2'')-Ie in a Japanese hospital.
    Watanabe S; Kobayashi N; Quiñones D; Nagashima S; Uehara N; Watanabe N
    Microb Drug Resist; 2009 Sep; 15(3):185-94. PubMed ID: 19728776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of vancomycin- and bifunctional aminoglycoside-resistant enterococci isolated from poultry farms in Malaysia.
    Chan YY; Abd Nasir MH; Yahaya MA; Salleh NM; Md Dan AD; Musa AM; Ravichandran M
    Int J Food Microbiol; 2008 Feb; 122(1-2):221-6. PubMed ID: 18187222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations.
    Tsuji BT; Bulitta JB; Brown T; Forrest A; Kelchlin PA; Holden PN; Peloquin CA; Skerlos L; Hanna D
    J Antimicrob Chemother; 2012 Sep; 67(9):2182-90. PubMed ID: 22685161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferable resistance and aminoglycoside-modifying enzymes in enterococci.
    Chen HY; Williams JD
    J Med Microbiol; 1985 Oct; 20(2):187-96. PubMed ID: 2995676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of high-level aminoglycoside resistance in vancomycin-sensitive and vancomycin-resistant Enterococcus species.
    Yazgi H; Ertek M; Erol S; Ayyildiz A
    J Int Med Res; 2002; 30(5):529-34. PubMed ID: 12449524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.
    Zarrilli R; Tripodi MF; Di Popolo A; Fortunato R; Bagattini M; Crispino M; Florio A; Triassi M; Utili R
    J Antimicrob Chemother; 2005 Nov; 56(5):827-35. PubMed ID: 16186168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro stepwise selection of reduced susceptibility to lipoglycopeptides in enterococci.
    Arhin FF; Seguin DL; Belley A; Moeck G
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):168-171. PubMed ID: 28733126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
    Arias CA; Singh KV; Panesso D; Murray BE
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2043-7. PubMed ID: 17438057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro susceptibility of Enterococcus strains to high level aminoglycosides and heavy metals].
    Nakipoğlu Y; Gümüş D; Sertel Selale D; Küçüker MA
    Mikrobiyol Bul; 2009 Oct; 43(4):545-51. PubMed ID: 20084907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
    LaPlante KL; Rybak MJ; Leuthner KD; Chin JN
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1298-303. PubMed ID: 16569844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus.
    Watanabe T; Ohashi K; Matsui K; Kubota T
    J Antimicrob Chemother; 1997 Apr; 39(4):471-6. PubMed ID: 9145819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
    Tabata M; Shimizu M; Araake M; Ogawa H
    Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.